Umang Swami, MD

Umang Swami, MD, University of Utah Health

Articles by Umang Swami, MD

Real-World Data Reveals Rise in mHSPC Treatment Intensification

Umang Swami, MDmCSPC | May 7, 2025

Drs. Swami and Ciuro discuss real-world data that indicates a shift in mHSPC treated with intensified therapy since 2023.

Cabozantinib Plus Immune Checkpoint Inhibitor Versus Cabozantinib Monotherapy in mccRCC

Umang Swami, MDAdvanced Renal Cell Carcinoma | May 1, 2024

Dr. Swami investigated the efficacy of cabozantinib in combination with immune checkpoint inhibitors for mccRCC.